Trial NCT04597359

To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring

This phase II trial studies how well green tea catechins work in preventing progression of
prostate cancer from a low risk stage to higher risk stages in men who are on active
surveillance. Green tea catechins may stabilize prostate cancer and lower the chance of
prostate growing.

Intervention

Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration, Sinecatechins

Condition

Prostate Carcinoma

Investigators

Nagi B Kumar, Richard L. Deming, Jay W. Carlson, Tareq Al Baghdadi, Prem Sobti, Bryan A. Faller, Thomas E. Lad, James A. Wallace, Howard M. Gross, Debra M. Prow, Joshua Lukenbill, Rex B. Mowat, David M. King, Douglas J. Weckstein, Brandon Mullins, Charles O. Kim, Stephen J. Savage, Steven A. Madden, Lisa Bailey, Mike Cusnir, Robert L. Grubb, Bradley C. Ekstrand, Paul D. Maroni, Ross E. Krasnow, Gopal R. Desai, Izak Faiena, Isuru S. Jayaratna, Marc Bjurlin, Kelly L. Stratton, Ryan P. Kopp, Edouard J. Trabulsi, Michael A. Liss, Inger L. Rosner

See list of participating sites